The Clinical Significance of Preformed C1q-binding Donor-specific HLA Antibodies in Kidney Transplantation

被引：0
|
作者：
Lee, S. [1 ]
Yang, C. [2 ]
Chung, B. [2 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul, South Korea
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1035
引用
收藏
页码：732 / 732
页数：1
相关论文
共 50 条
  • [41] Gradation of Immunological Risk According to Levels of Preformed Donor-Specific HLA Antibodies in Kidney Transplantation.
    Lefaucheur, Carmen
    Loupy, Alexandre
    Andrade, Joao
    Hill, Gary S.
    Nochy, Dominique
    Suberbielle-Boissel, Caroline
    Glotz, Denis
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 165 - 165
  • [42] The C1q-Binding Assays and Clinical Outcomes in Kidney Transplantation
    Amico, P.
    Hoenger, G.
    Hopfer, H.
    Liwski, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [43] The Prevalence and Clinical Significance of C1q Binding Donor-Specific Anti-HLA Antibodies in Patients With Functioning Allografts More Than 5 Years After Kidney Transplantation
    Calp-Inal, S.
    Colovai, A.
    Melamed, M.
    Masiakos, P.
    Turgut, D.
    Akalin, E.
    TRANSPLANTATION, 2014, 98 : 83 - 84
  • [44] The C1q-binding assays and clinical outcomes in kidney transplantation
    Honger, Gideon
    Hopfer, Helmut
    Schaub, Stefan
    Liwski, Robert
    Amico, Patrizia
    SWISS MEDICAL WEEKLY, 2014, 144 : 5S - 6S
  • [45] Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
    Uffing, Audrey
    Hidalgo, Luis G.
    McMullan, Giaran
    Perry, Jacqueline
    Milford, Edgar L.
    Murakami, Naoka
    Yeung, Melissa Y.
    Guleria, Indira
    Wood, Isabelle G.
    Akalin, Enver
    Azzi, Jamil
    Chandraker, Anil K.
    Riella, Leonardo, V
    TRANSPLANTATION DIRECT, 2019, 5 (05):
  • [46] Effect of complement inhibition therapy (eculizumab) in patients with C1q-binding donor-specific anti-HLA antibodies: A molecular appraisal
    Lefaucheur, Carmen
    Hidalgo, Luis
    Reeve, Jeff
    Viglietti, Denis
    Gosset, Clement
    Aubert, Olivier
    Ulloa, Camilo
    Legendre, Christophe
    Glotz, Denis
    Halloran, Philip
    Loupy, Alexandre
    TRANSPLANTATION, 2016, 100 (07) : S417 - S417
  • [47] Effect of Complement Inhibition Therapy (Eculizumab) in Patients with C1q-Binding Donor-Specific Anti-HLA Antibodies: A Molecular Appraisal
    Lefaucheur, C.
    Hidalgo, L.
    Reeve, J.
    Viglietti, D.
    Gosset, C.
    Aubert, O.
    Ulloa, C.
    Legendre, C.
    Glotz, D.
    Halloran, P.
    Loupy, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 273 - 273
  • [48] Donor-specific antibodies' C1q binding: improvement in kidney graft management?
    Ferrari-Lacraz, Sylvie
    TRANSPLANT INTERNATIONAL, 2017, 30 (04) : 344 - 346
  • [49] Defining Response to Standard of Care Treatment of Kidney Recipients with Antibody-Mediated Rejection: Role of C1q-binding Donor-specific Anti-HLA Antibodies
    Bouatou, Yassine
    Viglietti, Denis
    Aubert, Olivier
    Loupy, Alexandre
    Lefaucheur, Carmen
    TRANSPLANTATION, 2018, 102 : S5 - S5
  • [50] C1q-Binding Donor-Specific Anti-HLA Antibodies for Clinical Decision Making in Kidney Recipients with Antibody-Mediated Rejection Receiving Standard of Care Treatment.
    Lefaucheur, C.
    Viglietti, D.
    Bouatou, Y.
    Aubert, O.
    Zeevi, A.
    Loupy, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 510 - 510
12345